DK377986A - Farmaceutiske praeparater indeholdende en stabil fast molekylaer dispersion af 2-aryl-pyrazolo-quinoliner i polyvinylpyrrolidon - Google Patents

Farmaceutiske praeparater indeholdende en stabil fast molekylaer dispersion af 2-aryl-pyrazolo-quinoliner i polyvinylpyrrolidon Download PDF

Info

Publication number
DK377986A
DK377986A DK377986A DK377986A DK377986A DK 377986 A DK377986 A DK 377986A DK 377986 A DK377986 A DK 377986A DK 377986 A DK377986 A DK 377986A DK 377986 A DK377986 A DK 377986A
Authority
DK
Denmark
Prior art keywords
polyvinylpyrrolidon
aryl
pharmaceutical preparations
preparations containing
stable solid
Prior art date
Application number
DK377986A
Other languages
Danish (da)
English (en)
Other versions
DK377986D0 (da
Inventor
Lewis J Leeson
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of DK377986D0 publication Critical patent/DK377986D0/da
Publication of DK377986A publication Critical patent/DK377986A/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK377986A 1985-08-08 1986-08-07 Farmaceutiske praeparater indeholdende en stabil fast molekylaer dispersion af 2-aryl-pyrazolo-quinoliner i polyvinylpyrrolidon DK377986A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US76348985A 1985-08-08 1985-08-08

Publications (2)

Publication Number Publication Date
DK377986D0 DK377986D0 (da) 1986-08-07
DK377986A true DK377986A (da) 1987-02-09

Family

ID=25067966

Family Applications (1)

Application Number Title Priority Date Filing Date
DK377986A DK377986A (da) 1985-08-08 1986-08-07 Farmaceutiske praeparater indeholdende en stabil fast molekylaer dispersion af 2-aryl-pyrazolo-quinoliner i polyvinylpyrrolidon

Country Status (3)

Country Link
EP (1) EP0214092A1 (de)
JP (1) JPS6263519A (de)
DK (1) DK377986A (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3612212A1 (de) * 1986-04-11 1987-10-15 Basf Ag Verfahren zur herstellung von festen pharmazeutischen formen
US6524832B1 (en) 1994-02-04 2003-02-25 Arch Development Corporation DNA damaging agents in combination with tyrosine kinase inhibitors
GB9716345D0 (en) * 1997-08-01 1997-10-08 Merck Sharp & Dohme Therapeutic compounds
DE69821984T2 (de) * 1997-12-22 2004-12-30 Schering Corp. Zubereitung enthaltend eine molekulardispersion mit erhöhter bioverfügbarkeit
US6632455B2 (en) 1997-12-22 2003-10-14 Schering Corporation Molecular dispersion composition with enhanced bioavailability
US6316462B1 (en) 1999-04-09 2001-11-13 Schering Corporation Methods of inducing cancer cell death and tumor regression
DE19930454A1 (de) * 1999-07-02 2001-01-04 Knoll Ag Feste Paroxetin enthaltende Zubereitungen
EP2164328B8 (de) 2007-06-08 2013-09-11 Dart Neuroscience (Cayman) Ltd Therapeutische pyrazolochinolinharnstoffderivate
US7872002B2 (en) 2007-06-08 2011-01-18 Helicon Therapeutics, Inc. Therapeutic pyrazoloquinoline derivatives
WO2008154447A1 (en) 2007-06-08 2008-12-18 Helicon Therapeutics, Inc. Therapeutic pyrazolonaphthyridine derivatives

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES403326A1 (es) * 1971-06-04 1975-05-01 Boehringer Mannheim Gmbh Procedimiento para la granulacion de masas para tabletas enforma de polvo.
DE2634004B2 (de) * 1976-07-29 1978-08-10 Bernhard Dr. 8000 Muenchen Lippold Verfahren zur Beschleunigung der Auflösung und Verbesserung der Löslichkeit von schlechtlöslichen zur peroralen Verabreichung bestimmten Arzneistoffen
DE3013839A1 (de) * 1979-04-13 1980-10-30 Freunt Ind Co Ltd Verfahren zur herstellung einer aktivierten pharmazeutischen zusammensetzung
US4312870A (en) * 1979-06-21 1982-01-26 Ciba-Geigy Corporation Pyrazoloquinolines
FR2525108B1 (fr) * 1982-04-19 1989-05-12 Elan Corp Ltd Medicaments a haut degre de solubilite et procede pour leur obtention
US4459298A (en) * 1982-09-28 1984-07-10 Ciba-Geigy Corporation Method of suppressing appetite

Also Published As

Publication number Publication date
EP0214092A1 (de) 1987-03-11
JPS6263519A (ja) 1987-03-20
DK377986D0 (da) 1986-08-07

Similar Documents

Publication Publication Date Title
DK160985C (da) Asymmetriske diestere af 1,4-dihydro-2,6-dimethyl-pyridin-3,5-dicarboxylsyre, fremgangsmaader til fremstilling heraf samt farmaceutiske praeparater indeholdende disse
DK282986A (da) Substitueret quinolin og farmaceutisk praeparat indeholdende en saadan forbindelse
DK25992D0 (da) Quinolinderivater, deres fremstilling samt farmaeutisk praeparat indeholdende saadanne derivater
DK539786A (da) Tiazolo(4,5-c)quinoliner og laegemiddelpraeparater indeholdende saadanne forbindelser
DK456886A (da) Stabile frysetoerrede praeparater af et anticancer platinkompleks
DK404988D0 (da) Forbindelser hvori indgaar en faelles pyrrolstruktur og farmaceutiske praeparater med indhold af saadanne forbindelser
DK28787A (da) Thieno-1,4-diazepinforbindelser samt farmaceutiske praeparater med indhold af saadanne forbindelser
DK149988D0 (da) Stabile farmaceutiske praeparater
DK154085A (da) N-aryl-n-(4-piperidinyl)-amider samt farmaceutiske praeparater deraf
DK33287A (da) Imidazolanaloge af mevalonolacton og derivater deraf
DK162986C (da) 4-substituerede 2-amino-5-hydroxypyrimidin-forbindelser og farmaceutiske praeparater indeholdende disse
DK162518C (da) Fremgangsmaade til fremstilling af en stabil modifikation af torasemid, samt et farmaceutisk praeparat indeholdende denne
DK259186A (da) Nasale farmaceutiske praeparater
DK377986D0 (da) Farmaceutiske praeparater indeholdende en stabil fast molekylaer dispersion af 2-aryl-pyrazolo-quinoliner i polyvinylpyrrolidon
DK47787D0 (da) Dihydropyridinderivatholdige retardpraeparater
IL80799A0 (en) Substituted quinolones and pharmaceutical compositions containing them
DK312485A (da) Benzo(b)thiophen-derivater og farmaceutiske praeparater indeholdende disse
DK52086A (da) Farmaceutiske praeparater indeholdende ergotalkaloider
DK196885D0 (da) Farmaceutiske praeparater indeholdende isoquinolinderivater og isoquinolinderivater indeholdende saadanne derivater
DK162186A (da) Aminoketonderivater samt laegemidler indeholdende saadanne derivater
DK99085A (da) Farmaceutiske praeparater indeholdende a-vitaminsyrederivater
DK634486D0 (da) Molekylvaegtsbestemmelse af proteiner
FR2584069B1 (fr) Nouveaux maleimides et nouvelles compositions thermodurcissables les contenant.
DK22286A (da) 1,4-dihydropyridin-derivater og farmaceutiske praeparater indeholdende disse
DK202691D0 (da) Farmaceutiske praeparater, der indeholder farmaceutisk acceptable derivater af 3'-azido-3'-desoxythymidin

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment